Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears

Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears

"I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover. It will certainly be Oxford AstraZeneca, that I will be having," Boris Johnson said .

British Prime Minister Boris Johnson said on Wednesday he will take the vaccine developed by AstraZeneca after a number of European countries halted their rollout of the jab over safety fears.

Johnson dismissed questions in parliament about why several countries had suspended use of the product developed by the British-Swedish pharmaceutical company with scientists at Oxford University.

But he told lawmakers: "I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover.

"It will certainly be Oxford AstraZeneca, that I will be having."

Johnson, 56, is among the next category of people being called for vaccination. The government hopes to have offered it to all adults by July.

Health Secretary Matt Hancock said that timeline remains on track, despite the National Health Service in England warning in a letter to administrators that vaccine supplies will be "significantly constrained" from March 29 for up to a month.

"Vaccine supply is always lumpy and we regularly send out technical letters to the NHS to explain the ups and downs of the supply over the future weeks," Hancock told a news conference, insisting the letter was "standard" practice.

Britain has now given more than 25 million people a first dose of a Covid vaccine -- including 11 million doses of the AstraZeneca jab -- after starting a mass inoculation programme in December last year.

It is also using a jab developed by Pfizer/BioNTech in its rollout programme but recipients do not normally get a choice of vaccines.

Johnson wrote in the Times newspaper that the AstraZeneca vaccine "is safe and works extremely well". Hancock and England's deputy chief medical officer Jonathan Van-Tam echoed that assurance at the press conference.

- Royal intervention -


European countries including France, Spain and Germany are among those who have halted using the jab pending a review by the European Medicines Agency (EMA) amid feared links to blood clots and brain haemorrhages.

Queen Elizabeth II's oldest son and heir, Prince Charles, on Wednesday criticised opposition to coronavirus vaccines.

"Who would have thought, for instance, that in the 21st century that there would be a significant lobby opposing vaccination, given its track record in eradicating so many terrible diseases," he said in an article in the Future Healthcare Journal.

Charles, who has been vocal in advocating the rollout of the vaccine among more reluctant minority communities in Britain, added that the jab had the "potential to protect and liberate some of the most vulnerable in our society from coronavirus".

The 72-year-old Prince of Wales tested positive for coronavirus last year and suffered mild symptoms. He had his first dose of a vaccine in February.

His wife, Camilla, 73, confirmed on Tuesday she had been given the AstraZeneca shot.

"You take what you are given," she said as the couple visited a vaccination centre at a north London mosque, adding that she had suffered no ill-effects.

- 'No evidence' -


Professor Jeremy Brown, from the government's Joint Committee on Vaccination and Immunisation (JCVI), said suspension of the AstraZeneca jab was "not logical".

"There is the concern that what's happening in Europe might make people in the UK less confident in the AstraZeneca vaccine," he told broadcaster ITV.

The EMA, the World Health Organization and Britain's Medicines and Healthcare products Regulatory Agency have all backed the AstraZeneca jab.

France and Italy have said they will "promptly restart" giving the jab if the EMA review allows it.

As Britain has surged ahead with its vaccination programme, European countries have been accused of playing politics to distract from their sluggish inoculation rollouts.

European leaders were angered in January after AstraZeneca announced it was unable to deliver the agreed numbers of jabs to the bloc.

AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
Russia’s A7 Builds a State-Linked Payments Network Beyond Western Sanctions
AI’s Next Bottleneck Is Power, Not Just Nvidia Chips
Meta Raises AI Spending Target to as Much as $145bn Despite Pressure Over Returns
Danube Drought Exposes Nazi Wrecks and Pushes Central Europe’s Power System to the Brink
Joe Biden’s Cancer Has Spread Beyond His Bones, Hunter Biden Says
Why 2027 Could Be a Strong Year for Stocks—and Why the Forecast Is Fragile
Why Markets May Look Quiet in August After Big Tech Earnings
UK Drought Cuts Harvests and Raises Food-Security Fears
UFO: Pentagon Releases Video of Unidentified Object Tracked Over Middle East
Ukraine Tells Senate Republicans Its Drone War Offers a Blueprint for America
Weight-Loss Drug Boom Tests the Limits of Prescription Advertising Rules
Senate Scrutinises AI-Driven Personalised Pricing
Spain Seeks Mainland Transfers for 1,100 Children Stranded in Ceuta
Spain and Morocco Trade Blame After 72,000 Migrants Enter Ceuta
AI Is Remaking the US Economy, From GDP Growth to iPhone Prices
Europe’s Heat and Drought Are Now Disrupting Power, Shipping and Tourism
Europe’s Drying Rivers Trigger Power Cuts, Factory Shutdowns and Wildfire Emergencies
Record-Low Danube Forces Nuclear Cuts and Emergency Power Curbs
Danube Drought Forces Hungary’s Paks Nuclear Plant Into Full Shutdown
Ceuta Death Toll Rises as Spain and Europe Clash Over Border Response
Valued at $109 Million: F-35B Fighter Jet Crashes in Southern California
Record-Low Danube Exposes Probable Mammoth Remains in Bulgaria
US Says It Has Carried Out Heavy Strikes on Iran After Attempted Attacks on Its Forces
The AI User Nightmare: Private Claude Conversations Leaked to the Internet
Over 24 Hours in the Air: Qantas Airbus Completes Record-Breaking Test Flight
Massive Wildfires Ravage Southern Europe: Fatalities in Greece and Evacuations Across France, Spain, and Turkey
Nvidia Reportedly Takes Vast Texas Data-Centre Lease to Underwrite AI Expansion
FIFA’s Private-Investment Plan for World Cup Rights Draws European Revolt
Apple Briefly Crosses Five Trillion Dollar Valuation as Investors Retreat From AI Bets
Fresh Heatwave Threatens to Rekindle France’s Historic Wildfire Crisis
Following OpenAI's Cyberattack: 'Most Companies Still Do Not Understand What Is Coming'
OpenAI Sued After ChatGPT Allegedly Discouraged Emergency Care Before Near-Fatal Embolism
Miliband Sets Climate and International Law at Centre of UK Diplomacy
Czech Central Bank Governor Rejects Early Euro Entry and Rate-Cut Pressure
Trump Readies New Tariffs as Temporary Global Levy Nears Expiry
Vivienne Westwood Casts Cicciolina, 74, in Its New Autumn Campaign
Dejavu: Germany’s Military Expansion Reshapes Europe’s Strategic Balance With France
Morgan Stanley Builds a Wall Street Lead in AI Infrastructure Finance
High Prices Push Coffee Drinkers Toward Whole Beans and Home Brewing
Trump Draws Boos and Podium Scrutiny at Spain’s World Cup Triumph
Brilliant move: Péter Magyar Moves to Nominate Chess Grandmaster Judit Polgár as Hungary’s President
Spain Defeats Argentina in Extra Time to Win Second World Cup
Current AI Seeks to Build an Open Global AI Infrastructure Outside Big Tech Control
Germany’s Economic Malaise Reopens the Sunday Shopping Debate
Proposed U.S.-Saudi Nuclear Pact Could Permit Limited Uranium Enrichment Under International Safeguards
Netherlands Declares Water Shortage Emergency After Drought Pushes Rivers to Historic Lows
Why Kentucky Fried Chicken Became KFC—and Why the False Explanations Persist
Ukrainian Drones Strike Wildberries Warehouses Deep Inside Russia
Reported CIA Mission Helped Clear the UAE’s Path to Advanced US AI Chips
Artificial Intelligence Capital Fuels Markets While Governments and Regulators Face Mounting Strategic Tests
×